Signaturefd LLC reduced its position in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 25.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,333 shares of the company’s stock after selling 454 shares during the quarter. Signaturefd LLC’s holdings in HealthEquity were worth $109,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Sequoia Financial Advisors LLC raised its position in HealthEquity by 2.3% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 13,314 shares of the company’s stock worth $1,090,000 after purchasing an additional 303 shares during the period. Raymond James & Associates raised its position in HealthEquity by 1.3% in the 3rd quarter. Raymond James & Associates now owns 151,318 shares of the company’s stock worth $12,385,000 after purchasing an additional 1,911 shares during the period. AlphaMark Advisors LLC raised its position in HealthEquity by 18.8% in the 3rd quarter. AlphaMark Advisors LLC now owns 4,570 shares of the company’s stock worth $374,000 after purchasing an additional 722 shares during the period. Creative Planning increased its position in shares of HealthEquity by 18.6% during the third quarter. Creative Planning now owns 23,632 shares of the company’s stock worth $1,934,000 after acquiring an additional 3,706 shares during the period. Finally, Elk River Wealth Management LLC raised its stake in shares of HealthEquity by 0.3% during the third quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company’s stock valued at $5,417,000 after acquiring an additional 217 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several analysts have recently weighed in on HQY shares. Bank of America decreased their price target on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, September 4th. Barrington Research reaffirmed an “outperform” rating and set a $105.00 price target on shares of HealthEquity in a research note on Friday, September 20th. JMP Securities reaffirmed a “market outperform” rating and set a $105.00 price target on shares of HealthEquity in a research note on Wednesday, September 4th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $92.00 price target on shares of HealthEquity in a research note on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $103.83.
Insiders Place Their Bets
In other news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares in the company, valued at approximately $4,540,582.62. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, Director Frank Corvino sold 1,247 shares of HealthEquity stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the sale, the director now directly owns 4,823 shares in the company, valued at approximately $387,093.98. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now owns 54,719 shares of the company’s stock, valued at $4,540,582.62. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.
HealthEquity Price Performance
NASDAQ HQY opened at $87.82 on Tuesday. The firm’s fifty day simple moving average is $80.55 and its two-hundred day simple moving average is $79.79. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 12-month low of $61.81 and a 12-month high of $89.23. The firm has a market capitalization of $7.67 billion, a P/E ratio of 73.18, a P/E/G ratio of 1.37 and a beta of 0.52.
HealthEquity (NASDAQ:HQY – Get Free Report) last released its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The business had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. Analysts forecast that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
- Five stocks we like better than HealthEquity
- Financial Services Stocks Investing
- Inflation Risk Rising, Key Trades Investors Are Making Now
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- 3 Oil Stocks to Watch Before Earnings Come Out
- Find and Profitably Trade Stocks at 52-Week Lows
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.